Buffington Mohr Mc Neal Danaher Corp Transaction History

Buffington Mohr Mc Neal

  • $605 Million
  • Q3 2024

A detailed history of Buffington Mohr Mc Neal transactions in Danaher Corp stock. As of the latest transaction made, Buffington Mohr Mc Neal holds 62,785 shares of DHR stock, worth $14.8 Million. This represents 2.89% of its overall portfolio holdings.

Number of Shares
62,785
Previous 63,565 1.23%
Holding current value
$14.8 Million
Previous $15.9 Million 9.9%
% of portfolio
2.89%
Previous 2.79%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
SELL
$239.25 - $280.76 $186,615 - $218,992
-780 Reduced 1.23%
62,785 $17.5 Million
Q2 2024

Jul 11, 2024
SELL
$235.51 - $267.98 $5,887 - $6,699
-25 Reduced 0.04%
63,565 $15.9 Million
Q1 2024

Apr 18, 2024
SELL
$224.58 - $256.19 $100,836 - $115,029
-449 Reduced 0.7%
63,590 $15.9 Million
Q4 2023

Jan 30, 2024
SELL
$185.1 - $233.13 $276,354 - $348,063
-1,493 Reduced 2.28%
64,039 $14.8 Million
Q3 2023

Oct 25, 2023
SELL
$233.08 - $265.59 $123,299 - $140,497
-529 Reduced 0.8%
65,532 $16.3 Million
Q2 2023

Jul 25, 2023
SELL
$224.99 - $256.14 $2,474 - $2,817
-11 Reduced 0.02%
66,061 $15.9 Million
Q1 2023

Apr 26, 2023
SELL
$239.75 - $277.0 $6,233 - $7,202
-26 Reduced 0.04%
66,072 $16.7 Million
Q4 2022

Jan 19, 2023
SELL
$241.42 - $282.29 $3,621 - $4,234
-15 Reduced 0.02%
66,098 $0
Q3 2022

Oct 11, 2022
SELL
$247.06 - $1507.4 $109,941 - $670,793
-445 Reduced 0.67%
66,113 $17.1 Million
Q2 2022

Jul 19, 2022
SELL
$237.11 - $299.66 $130,410 - $164,813
-550 Reduced 0.82%
66,558 $16.9 Million
Q1 2022

May 02, 2022
SELL
$257.27 - $315.76 $341,911 - $419,645
-1,329 Reduced 1.94%
67,108 $19.7 Million
Q4 2021

Jan 27, 2022
SELL
$292.08 - $329.01 $116,539 - $131,274
-399 Reduced 0.58%
68,437 $22.5 Million
Q3 2021

Oct 13, 2021
SELL
$272.21 - $332.43 $662,831 - $809,467
-2,435 Reduced 3.42%
68,836 $21 Million
Q2 2021

Jul 28, 2021
SELL
$225.08 - $271.69 $19,356 - $23,365
-86 Reduced 0.12%
71,271 $19.1 Million
Q1 2021

Apr 14, 2021
SELL
$212.38 - $245.9 $14,017 - $16,229
-66 Reduced 0.09%
71,357 $16.1 Million
Q4 2020

Jan 20, 2021
BUY
$212.5 - $245.46 $119,000 - $137,457
560 Added 0.79%
71,423 $15.9 Million
Q3 2020

Oct 26, 2020
SELL
$177.16 - $215.33 $99,741 - $121,230
-563 Reduced 0.79%
70,863 $15.3 Million
Q2 2020

Jul 27, 2020
SELL
$128.7 - $176.83 $16,859 - $23,164
-131 Reduced 0.18%
71,426 $12.6 Million
Q1 2020

Apr 08, 2020
BUY
$121.39 - $169.05 $718,628 - $1 Million
5,920 Added 9.02%
71,557 $9.9 Million
Q4 2019

Jan 30, 2020
SELL
$133.47 - $153.48 $50,451 - $58,015
-378 Reduced 0.57%
65,637 $10.1 Million
Q3 2019

Oct 10, 2019
SELL
$135.4 - $146.47 $27,757 - $30,026
-205 Reduced 0.31%
66,015 $9.54 Million
Q2 2019

Jul 31, 2019
SELL
$124.88 - $143.73 $19,980 - $22,996
-160 Reduced 0.24%
66,220 $9.46 Million
Q1 2019

Apr 29, 2019
BUY
$97.62 - $132.29 $226,087 - $306,383
2,316 Added 3.62%
66,380 $8.76 Million
Q4 2018

Feb 07, 2019
SELL
$94.85 - $109.54 $101,489 - $117,207
-1,070 Reduced 1.64%
64,064 $6.61 Million
Q3 2018

Oct 25, 2018
BUY
$98.13 - $108.9 $494,280 - $548,529
5,037 Added 8.38%
65,134 $7.08 Million
Q2 2018

Jul 30, 2018
SELL
$96.1 - $103.24 $19,988 - $21,473
-208 Reduced 0.34%
60,097 $5.93 Million
Q1 2018

Apr 26, 2018
BUY
$92.16 - $103.8 $94,924 - $106,914
1,030 Added 1.74%
60,305 $5.9 Million
Q4 2017

Jan 25, 2018
SELL
$85.26 - $94.62 $17,478 - $19,397
-205 Reduced 0.34%
59,275 $5.5 Million
Q3 2017

Oct 30, 2017
BUY
$79.29 - $88.45 $4.72 Million - $5.26 Million
59,480
59,480 $5.49 Million

Others Institutions Holding DHR

# of Institutions
2,508
Shares Held
542M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Buffington Mohr Mc Neal Portfolio

Follow Buffington Mohr Mc Neal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buffington Mohr Mc Neal, based on Form 13F filings with the SEC.

News

Stay updated on Buffington Mohr Mc Neal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email